Using monoamine oxidase type B inhibitors in Parkinson's disease: They are effective and safe, at least when used alone
AUTOR(ES)
Ben-Shlomo, Yoav
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=516644Documentos Relacionados
- Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
- Coding of movement direction and amplitude in Parkinson's disease: are they differentially impaired (or unimportant)?
- Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow
- Are static posturography-assisted biofeedback exercises effective in Parkinson’s disease?
- Parkinson's disease: a journey